Clinical Consults on Modern AML Therapy: Where Precision Care Meets Potent Therapeutics
1.50 hr(s) | CME , MOC , ABIM
Therapeutic Area(s): Hematology , Oncology
Release Date: June 15, 2021
Expiration Date: June 15, 2021
Location: Live Webcast
The increasing availability and use of novel therapeutics has eclipsed the once-standard and widespread use of conventional chemotherapy for patients with acute myeloid leukemia (AML). The growing arsenal of innovative agents—which now includes newer cytotoxic formulations, epigenetic and targeted agents, and novel antibodies—has also afforded clinicians the opportunity to develop treatment protocols designed to address unmet medical needs in many different AML populations.